Please login to the form below
23
Revenue 2017Teva
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Teva's 2013 sales performance.
Back to the future
We have seen this in the relative demise of Teva, whose leadership thought it could be both innovative and low-cost.
FDA priority review for Roche’s Esbriet in unclassifiable interstitial lung disease
year. The Swiss pharma company already has an ongoing patent lawsuit against a number of generic drugmakers, including Novartis’ Sandoz division and Teva Pharmaceuticals, which are seeking to bring cheaper, generic
Pfizer, Sanofi and others set to increase US drug prices in 2021
Generic drugmaker Teva Pharmaceuticals has also raised the prices on 15 drugs, including rare neurological disorders drug Austedo (deutetrabenazine), asthma steroid Qvar (beclometasone) and more.
Roche gets EU approval for fixed-dose Herceptin/Perjeta combination
Herceptin has been hit by biosimilar competition, with much of the market share taken from Roche’s drug treatment by generic rivals from Amgen, Mylan, Pfizer, Teva and Merck &Co.
Virtual Reality Hub
by Teva. with support from earthware. One of the biggest challenges facing respiratory patients is misdiagnosis. ... Teva and earthware’s Virtual Reality Hub had good insight into healthcare professional needs.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Publications Director
-
Competitive Salary
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Account Manager
-
Salary TBC
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
-
Planner
-
Salary TBC
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- Merck signs $1.2bn supply deal with US government for Molnupiravir
- AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant
- Sanofi’s C1s inhibitor sutimlimab hits the mark in late-stage CAD study
- Israel finds a ‘probable link’ between Pfizer vaccine and myocarditis cases
- Your clinical trial participants are precious, so treat them as such
- Live Webinar: Helping Patients Become Active Participants in Their Own Care
- Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®
- Biogen, Sage’s depression therapeutic zuranolone hits primary endpoint in phase 3
- The power of communication: Engaging diverse groups in healthcare
- US trial data shows Novavax’s COVID-19 vaccine is 90% effective
- Merck signs $1.2bn supply deal with US government for Molnupiravir
- Diversity and inclusion in clinical trials
- Nicky Hutchens appointed as deputy managing director at Four Health
- FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision
- CanSinoBIO considers booster jab for COVID-19 vaccine
- Creston Health rebrands under Health Unlimited banner
PMHub
W2O Group
W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...
Latest intelligence
- Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®
- Some of the most popular and innovative ways of using our cutting-edge asynchronous and synchronous virtual tools for Medical Affairs teams....
- The power of communication: Engaging diverse groups in healthcare
- Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society - especially...
- Building the hospital of the future
- Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
